Cervical thoracic duct cysts occur infrequently but are an important consideration when evaluating cystic supraclavicular masses. Only 22 cases have been reported to date. We review the clinical presentation, evaluation, and treatment of 2 cases of large thoracic duct cysts treated with surgical resection. A high suspicion of thoracic duct cyst based on location, radiographic findings, and fine-needle aspiration results is sufficient evidence for recommendation of surgical excision. However, enlarged cysts, as noted in our cases, can obliterate or attenuate the thoracic duct, making it difficult to identify intraoperatively. A high suspicion of thoracic duct cyst is important for identifying and ligating the duct to prevent complications such as chyle leak or chylothorax.
Introduction
The differential diagnosis for left-sided neck masses is varied and includes congenital cysts as well as benign or malignant tumors. With only 22 reported cases, cervical thoracic duct cysts (TDCs) are rare but important entities to consider because of the risk of chyle leak if the thoracic duct is not identified and ligated during surgery. [1] [2] [3] [4] [5] [6] We present 2 cases of large TDCs treated with surgical resection and review the characteristic clinical and radiographic findings, as well as available treatment options, for these rare lesions.
Case reports Patient 1.
A 38-year-old man with no history of neck trauma or surgery presented with a painless, slowly enlarging left neck mass present for 1.5 years. Examination revealed a large cystic mass in the left supraclavicular fossa. Fine-needle aspiration (FNA) returned proteinaceous fluid with many lymphocytes and was negative for malignant cells. Computed tomography (CT) of the neck demonstrated a 9-cm cystic mass located posterior to the sternocleidomastoid muscle causing medial displacement of the great vessels (figure 1). Surgical findings revealed a 13 × 8-cm mass with extension A 49-year-old woman with a history of total thyroidectomy 22 years previously at an outside hospital (pathology unknown) presented with a 5-month history of left neck swelling. She was otherwise asymptomatic. On examination, a 5-cm, soft, cystic mass in the left supraclavicular fossa was found. Ultrasonography showed an anechoic cystic mass.
FNA returned a monotonous population of lymphocytes in a proteinaceous background. Surgical exploration revealed a 5 × 6-cm cystic mass posterior to the sternocleidomastoid muscle and lateral to the great vessels with infraclavicular extension. The final pathology revealed a benign cyst with endothelial lining, which was confirmed by immunohistochemical staining, showing CD31 positivity ( figure 5 ). Postoperatively, the patient did well without any complications or recurrence.
Discussion
The thoracic duct originates in the abdomen from the cysterna chyli and travels upward along the right side of the spine to thoracic vertebrae T5 to T6, where it crosses over to the left to run between the aorta and azygos vein. After passing through the mediastinum, it enters the left neck posterior to the innominate artery and arches 3 to 5 cm above the clavicle.
The cervical portion of the thoracic duct typically lies posterior to the common carotid artery and internal jugular vein, where it empties into the junction of the subclavian and internal jugular veins. The wall of the thoracic duct in the cervical region is composed of a thin layer of connective tissue and smooth muscle with an endothelial lining. 1, 7 The pathogenesis of TDC is uncertain, but several mechanisms have been postulated, including congenital weakness of the thoracic duct wall, acquired degenerative changes (due to inflammation, atherosclerosis, infection, or trauma), or obstruction at the terminal end of the duct. 1, 6, 7 Potential sources of acquired thoracic duct wall degeneration in our patients include hypertriglyceridemia in the first patient and previous neck surgery in the second patient.
TDC may cause compressive symptoms such as dysphagia or dyspnea, but up to half of patients remain asymptomatic. 7 This was true of our patients despite the large size of the cysts. Ultrasonography is useful for confirming the cystic nature of these lesions, as they appear anechoic. CT imaging helps define anatomic boundaries and determine intrathoracic extension. FNA can help to rule out malignancy.
Characteristic findings for TDC include a predominance of T-lymphocytes (90 to 95%) and high triglyceride levels. Staining of cyst lining with immunohistochemical markers can confirm the presence of endothelial cells (CD31, CD34, factor VIII) and rule out epithelial or mesothelial components. 1 Although conservative management with dietary changes, needle aspiration, and sclerotherapy have been described, most TDCs are treated with surgical resection. 2, 5 Care must be taken during surgery to identify and ligate the thoracic duct and communicating lymphatic branches to prevent chyle leak or chylothorax.
In conclusion, cervical TDC is a rare clinical entity. A high suspicion for TDC based on location, together with radiographic and cytologic findings, is sufficient for surgical excision. However, enlarged cysts, as noted in our cases, can obliterate or attenuate the thoracic duct, making its identification during surgery difficult. Maintaining a high suspicion for TDC is important in identifying and ligating the duct to prevent complications such as chylothorax. 
